循環腫瘍細胞（CTC）診断の世界市場 2020年：企業別、地域別、種類・用途別

• 英文タイトル：Global Circulating Tumor Cell (CTC) Diagnostics Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：D0804-15525 • 出版社/出版日：GlobalInfoResearch / 2020年7月28日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、122ページ • 納品方法：Eメール • 産業分類：医療

• 販売価格（消費税別）

Single User	￥487,200 (USD3,480)	▷ お問い合わせ
Multi User	￥730,800 (USD5,220)	▷ お問い合わせ
Corporate User	￥974,400 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査レポートでは、循環腫瘍細胞（CTC）診断の世界市場を広く調査・分析し、今後の市場展望をまとめております。循環腫瘍細胞（CTC）診断の種類別市場規模（CTC濃縮、CTC検出）、用途別市場規模（病院・クリニック、製薬・バイオテクノロジー企業、学術研究機関、CRO）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：ApoCell, Inc.(US)、CynvenioBiosystems, Inc.(US)、Biofluidica MicrotechnologiesLLc(US)、Biocep Ltd. (Israel)、Creatv Microtech, Inc.(US)、Biocept, Inc.(US)、FluxionBiosciences, Inc.(US)、ClearbridgeBiomedics(Singapore)、Celltraffix Inc.(US)、EpicBiosciencesInc.(US)、RARECELLsSAs(Italy)、Ikonisys, Inc.(US)、ScreenCell(France)、QIAGEnHannoverGmbH (Germany)、IVDiagnostics, Inc.(US)、STEMCELlTechnologies, Inc.(Canada)、JanssenDiagnosticsLLc(US) ・地域別グローバル市場分析 2015年-2020年 ・循環腫瘍細胞（CTC）診断の北米市場（アメリカ、カナダ、メキシコ） ・循環腫瘍細胞（CTC）診断のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・循環腫瘍細胞（CTC）診断のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・循環腫瘍細胞（CTC）診断の南米市場（ブラジル、アルゼンチン） ・循環腫瘍細胞（CTC）診断の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：CTC濃縮、CTC検出 ・用途別分析：病院・クリニック、製薬・バイオテクノロジー企業、学術研究機関、CRO ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論

Market Overview
The global Circulating Tumor Cell (CTC) Diagnostics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Circulating Tumor Cell (CTC) Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Circulating Tumor Cell (CTC) Diagnostics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Circulating Tumor Cell (CTC) Diagnostics market has been segmented into:
CTC Enrichment
CTC Detection

By Application, Circulating Tumor Cell (CTC) Diagnostics has been segmented into:
Hospitals and clinics
Pharmaceuticals and biotechnology companies
Academic research institutes
CROs

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Circulating Tumor Cell (CTC) Diagnostics market presented in the report. This section sheds light on the sales growth of different regional and country-level Circulating Tumor Cell (CTC) Diagnostics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Circulating Tumor Cell (CTC) Diagnostics market.

The report offers in-depth assessment of the growth and other aspects of the Circulating Tumor Cell (CTC) Diagnostics market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Circulating Tumor Cell (CTC) Diagnostics Market Share Analysis
Circulating Tumor Cell (CTC) Diagnostics competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Circulating Tumor Cell (CTC) Diagnostics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Circulating Tumor Cell (CTC) Diagnostics sales, revenue and market share for each player covered in this report.

The major players covered in Circulating Tumor Cell (CTC) Diagnostics are:
ApoCell, Inc.(US)
CynvenioBiosystems, Inc.(US)
Biofluidica MicrotechnologiesLLc(US)
Biocep Ltd. (Israel)
Creatv Microtech, Inc.(US)
Biocept, Inc.(US)
FluxionBiosciences, Inc.(US)
ClearbridgeBiomedics(Singapore)
Celltraffix Inc.(US)
EpicBiosciencesInc.(US)
RARECELLsSAs(Italy)
Ikonisys, Inc.(US)
ScreenCell(France)
QIAGEnHannoverGmbH (Germany)
IVDiagnostics, Inc.(US)
STEMCELlTechnologies, Inc.(Canada)
JanssenDiagnosticsLLc(US)

レポート目次

---

Table of Contents

1 Circulating Tumor Cell (CTC) Diagnostics Market Overview
1.1 Product Overview and Scope of Circulating Tumor Cell (CTC) Diagnostics
1.2 Classification of Circulating Tumor Cell (CTC) Diagnostics by Type
1.2.1 Global Circulating Tumor Cell (CTC) Diagnostics Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share by Type in 2019
1.2.3 CTC Enrichment
1.2.4 CTC Detection
1.3 Global Circulating Tumor Cell (CTC) Diagnostics Market by Application
1.3.1 Overview: Global Circulating Tumor Cell (CTC) Diagnostics Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals and clinics
1.3.3 Pharmaceuticals and biotechnology companies
1.3.4 Academic research institutes
1.3.5 CROs
1.4 Global Circulating Tumor Cell (CTC) Diagnostics Market by Regions
1.4.1 Global Circulating Tumor Cell (CTC) Diagnostics Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Circulating Tumor Cell (CTC) Diagnostics (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Circulating Tumor Cell (CTC) Diagnostics Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Circulating Tumor Cell (CTC) Diagnostics Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Circulating Tumor Cell (CTC) Diagnostics Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Circulating Tumor Cell (CTC) Diagnostics Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Circulating Tumor Cell (CTC) Diagnostics Status and Prospect (2015-2025)
2 Company Profiles
2.1 ApoCell, Inc.(US)
2.1.1 ApoCell, Inc.(US) Details
2.1.2 ApoCell, Inc.(US) Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 ApoCell, Inc.(US) SWOT Analysis
2.1.4 ApoCell, Inc.(US) Product and Services
2.1.5 ApoCell, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.2 CynvenioBiosystems, Inc.(US)
2.2.1 CynvenioBiosystems, Inc.(US) Details
2.2.2 CynvenioBiosystems, Inc.(US) Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 CynvenioBiosystems, Inc.(US) SWOT Analysis
2.2.4 CynvenioBiosystems, Inc.(US) Product and Services
2.2.5 CynvenioBiosystems, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.3 Biofluidica MicrotechnologiesLLc(US)
2.3.1 Biofluidica MicrotechnologiesLLc(US) Details
2.3.2 Biofluidica MicrotechnologiesLLc(US) Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Biofluidica MicrotechnologiesLLc(US) SWOT Analysis
2.3.4 Biofluidica MicrotechnologiesLLc(US) Product and Services
2.3.5 Biofluidica MicrotechnologiesLLc(US) Circulating Tumor Cell (CTC) Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.4 Biocep Ltd. (Israel)
2.4.1 Biocep Ltd. (Israel) Details
2.4.2 Biocep Ltd. (Israel) Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Biocep Ltd. (Israel) SWOT Analysis
2.4.4 Biocep Ltd. (Israel) Product and Services
2.4.5 Biocep Ltd. (Israel) Circulating Tumor Cell (CTC) Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.5 Creatv Microtech, Inc.(US)
2.5.1 Creatv Microtech, Inc.(US) Details
2.5.2 Creatv Microtech, Inc.(US) Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Creatv Microtech, Inc.(US) SWOT Analysis
2.5.4 Creatv Microtech, Inc.(US) Product and Services
2.5.5 Creatv Microtech, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.6 Biocept, Inc.(US)
2.6.1 Biocept, Inc.(US) Details
2.6.2 Biocept, Inc.(US) Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Biocept, Inc.(US) SWOT Analysis
2.6.4 Biocept, Inc.(US) Product and Services
2.6.5 Biocept, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.7 FluxionBiosciences, Inc.(US)
2.7.1 FluxionBiosciences, Inc.(US) Details
2.7.2 FluxionBiosciences, Inc.(US) Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 FluxionBiosciences, Inc.(US) SWOT Analysis
2.7.4 FluxionBiosciences, Inc.(US) Product and Services
2.7.5 FluxionBiosciences, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.8 ClearbridgeBiomedics(Singapore)
2.8.1 ClearbridgeBiomedics(Singapore) Details
2.8.2 ClearbridgeBiomedics(Singapore) Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 ClearbridgeBiomedics(Singapore) SWOT Analysis
2.8.4 ClearbridgeBiomedics(Singapore) Product and Services
2.8.5 ClearbridgeBiomedics(Singapore) Circulating Tumor Cell (CTC) Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.9 Celltraffix Inc.(US)
2.9.1 Celltraffix Inc.(US) Details
2.9.2 Celltraffix Inc.(US) Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Celltraffix Inc.(US) SWOT Analysis
2.9.4 Celltraffix Inc.(US) Product and Services
2.9.5 Celltraffix Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.10 EpicBiosciencesInc.(US)
2.10.1 EpicBiosciencesInc.(US) Details
2.10.2 EpicBiosciencesInc.(US) Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 EpicBiosciencesInc.(US) SWOT Analysis
2.10.4 EpicBiosciencesInc.(US) Product and Services
2.10.5 EpicBiosciencesInc.(US) Circulating Tumor Cell (CTC) Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.11 RARECELLsSAs(Italy)
2.11.1 RARECELLsSAs(Italy) Details
2.11.2 RARECELLsSAs(Italy) Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 RARECELLsSAs(Italy) SWOT Analysis
2.11.4 RARECELLsSAs(Italy) Product and Services
2.11.5 RARECELLsSAs(Italy) Circulating Tumor Cell (CTC) Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.12 Ikonisys, Inc.(US)
2.12.1 Ikonisys, Inc.(US) Details
2.12.2 Ikonisys, Inc.(US) Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Ikonisys, Inc.(US) SWOT Analysis
2.12.4 Ikonisys, Inc.(US) Product and Services
2.12.5 Ikonisys, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.13 ScreenCell(France)
2.13.1 ScreenCell(France) Details
2.13.2 ScreenCell(France) Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 ScreenCell(France) SWOT Analysis
2.13.4 ScreenCell(France) Product and Services
2.13.5 ScreenCell(France) Circulating Tumor Cell (CTC) Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.14 QIAGEnHannoverGmbH (Germany)
2.14.1 QIAGEnHannoverGmbH (Germany) Details
2.14.2 QIAGEnHannoverGmbH (Germany) Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 QIAGEnHannoverGmbH (Germany) SWOT Analysis
2.14.4 QIAGEnHannoverGmbH (Germany) Product and Services
2.14.5 QIAGEnHannoverGmbH (Germany) Circulating Tumor Cell (CTC) Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.15 IVDiagnostics, Inc.(US)
2.15.1 IVDiagnostics, Inc.(US) Details
2.15.2 IVDiagnostics, Inc.(US) Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 IVDiagnostics, Inc.(US) SWOT Analysis
2.15.4 IVDiagnostics, Inc.(US) Product and Services
2.15.5 IVDiagnostics, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.16 STEMCELlTechnologies, Inc.(Canada)
2.16.1 STEMCELlTechnologies, Inc.(Canada) Details
2.16.2 STEMCELlTechnologies, Inc.(Canada) Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 STEMCELlTechnologies, Inc.(Canada) SWOT Analysis
2.16.4 STEMCELlTechnologies, Inc.(Canada) Product and Services
2.16.5 STEMCELlTechnologies, Inc.(Canada) Circulating Tumor Cell (CTC) Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.17 JanssenDiagnosticsLLc(US)
2.17.1 JanssenDiagnosticsLLc(US) Details
2.17.2 JanssenDiagnosticsLLc(US) Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 JanssenDiagnosticsLLc(US) SWOT Analysis
2.17.4 JanssenDiagnosticsLLc(US) Product and Services
2.17.5 JanssenDiagnosticsLLc(US) Circulating Tumor Cell (CTC) Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Circulating Tumor Cell (CTC) Diagnostics Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Circulating Tumor Cell (CTC) Diagnostics Players Market Share
3.2.2 Top 10 Circulating Tumor Cell (CTC) Diagnostics Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Circulating Tumor Cell (CTC) Diagnostics Revenue and Market Share by Regions
4.2 North America Circulating Tumor Cell (CTC) Diagnostics Revenue and Growth Rate (2015-2020)
4.3 Europe Circulating Tumor Cell (CTC) Diagnostics Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics Revenue and Growth Rate (2015-2020)
4.5 South America Circulating Tumor Cell (CTC) Diagnostics Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Revenue and Growth Rate (2015-2020)
5 North America Circulating Tumor Cell (CTC) Diagnostics Revenue by Countries
5.1 North America Circulating Tumor Cell (CTC) Diagnostics Revenue by Countries (2015-2020)
5.2 USA Circulating Tumor Cell (CTC) Diagnostics Revenue and Growth Rate (2015-2020)
5.3 Canada Circulating Tumor Cell (CTC) Diagnostics Revenue and Growth Rate (2015-2020)
5.4 Mexico Circulating Tumor Cell (CTC) Diagnostics Revenue and Growth Rate (2015-2020)
6 Europe Circulating Tumor Cell (CTC) Diagnostics Revenue by Countries
6.1 Europe Circulating Tumor Cell (CTC) Diagnostics Revenue by Countries (2015-2020)
6.2 Germany Circulating Tumor Cell (CTC) Diagnostics Revenue and Growth Rate (2015-2020)
6.3 UK Circulating Tumor Cell (CTC) Diagnostics Revenue and Growth Rate (2015-2020)
6.4 France Circulating Tumor Cell (CTC) Diagnostics Revenue and Growth Rate (2015-2020)
6.5 Russia Circulating Tumor Cell (CTC) Diagnostics Revenue and Growth Rate (2015-2020)
6.6 Italy Circulating Tumor Cell (CTC) Diagnostics Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics Revenue by Countries
7.1 Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics Revenue by Countries (2015-2020)
7.2 China Circulating Tumor Cell (CTC) Diagnostics Revenue and Growth Rate (2015-2020)
7.3 Japan Circulating Tumor Cell (CTC) Diagnostics Revenue and Growth Rate (2015-2020)
7.4 Korea Circulating Tumor Cell (CTC) Diagnostics Revenue and Growth Rate (2015-2020)
7.5 India Circulating Tumor Cell (CTC) Diagnostics Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Circulating Tumor Cell (CTC) Diagnostics Revenue and Growth Rate (2015-2020)
8 South America Circulating Tumor Cell (CTC) Diagnostics Revenue by Countries
8.1 South America Circulating Tumor Cell (CTC) Diagnostics Revenue by Countries (2015-2020)
8.2 Brazil Circulating Tumor Cell (CTC) Diagnostics Revenue and Growth Rate (2015-2020)
8.3 Argentina Circulating Tumor Cell (CTC) Diagnostics Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Circulating Tumor Cell (CTC) Diagnostics by Countries
9.1 Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Revenue by Countries (2015-2020)
9.2 Saudi Arabia Circulating Tumor Cell (CTC) Diagnostics Revenue and Growth Rate (2015-2020)
9.3 UAE Circulating Tumor Cell (CTC) Diagnostics Revenue and Growth Rate (2015-2020)
9.4 Egypt Circulating Tumor Cell (CTC) Diagnostics Revenue and Growth Rate (2015-2020)
9.5 South Africa Circulating Tumor Cell (CTC) Diagnostics Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Circulating Tumor Cell (CTC) Diagnostics Revenue and Market Share by Type (2015-2020)
10.2 Global Circulating Tumor Cell (CTC) Diagnostics Market Forecast by Type (2019-2024)
10.3 CTC Enrichment Revenue Growth Rate (2015-2025)
10.4 CTC Detection Revenue Growth Rate (2015-2025)
11 Global Circulating Tumor Cell (CTC) Diagnostics Market Segment by Application
11.1 Global Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share by Application (2015-2020)
11.2 Circulating Tumor Cell (CTC) Diagnostics Market Forecast by Application (2019-2024)
11.3 Hospitals and clinics Revenue Growth (2015-2020)
11.4 Pharmaceuticals and biotechnology companies Revenue Growth (2015-2020)
11.5 Academic research institutes Revenue Growth (2015-2020)
11.6 CROs Revenue Growth (2015-2020)
12 Global Circulating Tumor Cell (CTC) Diagnostics Market Size Forecast (2021-2025)
12.1 Global Circulating Tumor Cell (CTC) Diagnostics Market Size Forecast (2021-2025)
12.2 Global Circulating Tumor Cell (CTC) Diagnostics Market Forecast by Regions (2021-2025)
12.3 North America Circulating Tumor Cell (CTC) Diagnostics Revenue Market Forecast (2021-2025)
12.4 Europe Circulating Tumor Cell (CTC) Diagnostics Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics Revenue Market Forecast (2021-2025)
12.6 South America Circulating Tumor Cell (CTC) Diagnostics Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Circulating Tumor Cell (CTC) Diagnostics Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Circulating Tumor Cell (CTC) Diagnostics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Circulating Tumor Cell (CTC) Diagnostics Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Circulating Tumor Cell (CTC) Diagnostics Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. ApoCell, Inc.(US) Corporate Information, Location and Competitors
Table 6. ApoCell, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Major Business
Table 7. ApoCell, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Total Revenue (USD Million) (2017-2018)
Table 8. ApoCell, Inc.(US) SWOT Analysis
Table 9. ApoCell, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Product and Solutions
Table 10. ApoCell, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. CynvenioBiosystems, Inc.(US) Corporate Information, Location and Competitors
Table 12. CynvenioBiosystems, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Major Business
Table 13. CynvenioBiosystems, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Total Revenue (USD Million) (2018-2019)
Table 14. CynvenioBiosystems, Inc.(US) SWOT Analysis
Table 15. CynvenioBiosystems, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Product and Solutions
Table 16. CynvenioBiosystems, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Biofluidica MicrotechnologiesLLc(US) Corporate Information, Location and Competitors
Table 18. Biofluidica MicrotechnologiesLLc(US) Circulating Tumor Cell (CTC) Diagnostics Major Business
Table 19. Biofluidica MicrotechnologiesLLc(US) Circulating Tumor Cell (CTC) Diagnostics Total Revenue (USD Million) (2017-2018)
Table 20. Biofluidica MicrotechnologiesLLc(US) SWOT Analysis
Table 21. Biofluidica MicrotechnologiesLLc(US) Circulating Tumor Cell (CTC) Diagnostics Product and Solutions
Table 22. Biofluidica MicrotechnologiesLLc(US) Circulating Tumor Cell (CTC) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Biocep Ltd. (Israel) Corporate Information, Location and Competitors
Table 24. Biocep Ltd. (Israel) Circulating Tumor Cell (CTC) Diagnostics Major Business
Table 25. Biocep Ltd. (Israel) Circulating Tumor Cell (CTC) Diagnostics Total Revenue (USD Million) (2017-2018)
Table 26. Biocep Ltd. (Israel) SWOT Analysis
Table 27. Biocep Ltd. (Israel) Circulating Tumor Cell (CTC) Diagnostics Product and Solutions
Table 28. Biocep Ltd. (Israel) Circulating Tumor Cell (CTC) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Creatv Microtech, Inc.(US) Corporate Information, Location and Competitors
Table 30. Creatv Microtech, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Major Business
Table 31. Creatv Microtech, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Total Revenue (USD Million) (2017-2018)
Table 32. Creatv Microtech, Inc.(US) SWOT Analysis
Table 33. Creatv Microtech, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Product and Solutions
Table 34. Creatv Microtech, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Biocept, Inc.(US) Corporate Information, Location and Competitors
Table 36. Biocept, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Major Business
Table 37. Biocept, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Total Revenue (USD Million) (2017-2018)
Table 38. Biocept, Inc.(US) SWOT Analysis
Table 39. Biocept, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Product and Solutions
Table 40. Biocept, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. FluxionBiosciences, Inc.(US) Corporate Information, Location and Competitors
Table 42. FluxionBiosciences, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Major Business
Table 43. FluxionBiosciences, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Total Revenue (USD Million) (2017-2018)
Table 44. FluxionBiosciences, Inc.(US) SWOT Analysis
Table 45. FluxionBiosciences, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Product and Solutions
Table 46. FluxionBiosciences, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. ClearbridgeBiomedics(Singapore) Corporate Information, Location and Competitors
Table 48. ClearbridgeBiomedics(Singapore) Circulating Tumor Cell (CTC) Diagnostics Major Business
Table 49. ClearbridgeBiomedics(Singapore) Circulating Tumor Cell (CTC) Diagnostics Total Revenue (USD Million) (2017-2018)
Table 50. ClearbridgeBiomedics(Singapore) SWOT Analysis
Table 51. ClearbridgeBiomedics(Singapore) Circulating Tumor Cell (CTC) Diagnostics Product and Solutions
Table 52. ClearbridgeBiomedics(Singapore) Circulating Tumor Cell (CTC) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Celltraffix Inc.(US) Corporate Information, Location and Competitors
Table 54. Celltraffix Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Major Business
Table 55. Celltraffix Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Total Revenue (USD Million) (2017-2018)
Table 56. Celltraffix Inc.(US) SWOT Analysis
Table 57. Celltraffix Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Product and Solutions
Table 58. Celltraffix Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. EpicBiosciencesInc.(US) Corporate Information, Location and Competitors
Table 60. EpicBiosciencesInc.(US) Circulating Tumor Cell (CTC) Diagnostics Major Business
Table 61. EpicBiosciencesInc.(US) Circulating Tumor Cell (CTC) Diagnostics Total Revenue (USD Million) (2017-2018)
Table 62. EpicBiosciencesInc.(US) SWOT Analysis
Table 63. EpicBiosciencesInc.(US) Circulating Tumor Cell (CTC) Diagnostics Product and Solutions
Table 64. EpicBiosciencesInc.(US) Circulating Tumor Cell (CTC) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. RARECELLsSAs(Italy) Corporate Information, Location and Competitors
Table 66. RARECELLsSAs(Italy) Circulating Tumor Cell (CTC) Diagnostics Major Business
Table 67. RARECELLsSAs(Italy) Circulating Tumor Cell (CTC) Diagnostics Total Revenue (USD Million) (2017-2018)
Table 68. RARECELLsSAs(Italy) SWOT Analysis
Table 69. RARECELLsSAs(Italy) Circulating Tumor Cell (CTC) Diagnostics Product and Solutions
Table 70. RARECELLsSAs(Italy) Circulating Tumor Cell (CTC) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Ikonisys, Inc.(US) Corporate Information, Location and Competitors
Table 72. Ikonisys, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Major Business
Table 73. Ikonisys, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Total Revenue (USD Million) (2017-2018)
Table 74. Ikonisys, Inc.(US) SWOT Analysis
Table 75. Ikonisys, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Product and Solutions
Table 76. Ikonisys, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. ScreenCell(France) Corporate Information, Location and Competitors
Table 78. ScreenCell(France) Circulating Tumor Cell (CTC) Diagnostics Major Business
Table 79. ScreenCell(France) Circulating Tumor Cell (CTC) Diagnostics Total Revenue (USD Million) (2017-2018)
Table 80. ScreenCell(France) SWOT Analysis
Table 81. ScreenCell(France) Circulating Tumor Cell (CTC) Diagnostics Product and Solutions
Table 82. ScreenCell(France) Circulating Tumor Cell (CTC) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. QIAGEnHannoverGmbH (Germany) Corporate Information, Location and Competitors
Table 84. QIAGEnHannoverGmbH (Germany) Circulating Tumor Cell (CTC) Diagnostics Major Business
Table 85. QIAGEnHannoverGmbH (Germany) Circulating Tumor Cell (CTC) Diagnostics Total Revenue (USD Million) (2017-2018)
Table 86. QIAGEnHannoverGmbH (Germany) SWOT Analysis
Table 87. QIAGEnHannoverGmbH (Germany) Circulating Tumor Cell (CTC) Diagnostics Product and Solutions
Table 88. QIAGEnHannoverGmbH (Germany) Circulating Tumor Cell (CTC) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 89. IVDiagnostics, Inc.(US) Corporate Information, Location and Competitors
Table 90. IVDiagnostics, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Major Business
Table 91. IVDiagnostics, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Total Revenue (USD Million) (2017-2018)
Table 92. IVDiagnostics, Inc.(US) SWOT Analysis
Table 93. IVDiagnostics, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Product and Solutions
Table 94. IVDiagnostics, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 95. STEMCELlTechnologies, Inc.(Canada) Corporate Information, Location and Competitors
Table 96. STEMCELlTechnologies, Inc.(Canada) Circulating Tumor Cell (CTC) Diagnostics Major Business
Table 97. STEMCELlTechnologies, Inc.(Canada) Circulating Tumor Cell (CTC) Diagnostics Total Revenue (USD Million) (2017-2018)
Table 98. STEMCELlTechnologies, Inc.(Canada) SWOT Analysis
Table 99. STEMCELlTechnologies, Inc.(Canada) Circulating Tumor Cell (CTC) Diagnostics Product and Solutions
Table 100. STEMCELlTechnologies, Inc.(Canada) Circulating Tumor Cell (CTC) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 101. JanssenDiagnosticsLLc(US) Corporate Information, Location and Competitors
Table 102. JanssenDiagnosticsLLc(US) Circulating Tumor Cell (CTC) Diagnostics Major Business
Table 103. JanssenDiagnosticsLLc(US) Circulating Tumor Cell (CTC) Diagnostics Total Revenue (USD Million) (2017-2018)
Table 104. JanssenDiagnosticsLLc(US) SWOT Analysis
Table 105. JanssenDiagnosticsLLc(US) Circulating Tumor Cell (CTC) Diagnostics Product and Solutions
Table 106. JanssenDiagnosticsLLc(US) Circulating Tumor Cell (CTC) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 107. Global Circulating Tumor Cell (CTC) Diagnostics Revenue (Million USD) by Players (2015-2020)
Table 108. Global Circulating Tumor Cell (CTC) Diagnostics Revenue Share by Players (2015-2020)
Table 109. Global Circulating Tumor Cell (CTC) Diagnostics Revenue (Million USD) by Regions (2015-2020)
Table 110. Global Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share by Regions (2015-2020)
Table 111. North America Circulating Tumor Cell (CTC) Diagnostics Revenue by Countries (2015-2020)
Table 112. North America Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share by Countries (2015-2020)
Table 113. Europe Circulating Tumor Cell (CTC) Diagnostics Revenue (Million USD) by Countries (2015-2020)
Table 114. Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics Revenue (Million USD) by Countries (2015-2020)
Table 115. South America Circulating Tumor Cell (CTC) Diagnostics Revenue by Countries (2015-2020)
Table 116. South America Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share by Countries (2015-2020)
Table 117. Middle East and Africa Circulating Tumor Cell (CTC) Diagnostics Revenue (Million USD) by Countries (2015-2020)
Table 118. Middle East and Africa Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share by Countries (2015-2020)
Table 119. Global Circulating Tumor Cell (CTC) Diagnostics Revenue (Million USD) by Type (2015-2020)
Table 120. Global Circulating Tumor Cell (CTC) Diagnostics Revenue Share by Type (2015-2020)
Table 121. Global Circulating Tumor Cell (CTC) Diagnostics Revenue Forecast by Type (2021-2025)
Table 122. Global Circulating Tumor Cell (CTC) Diagnostics Revenue by Application (2015-2020)
Table 123. Global Circulating Tumor Cell (CTC) Diagnostics Revenue Share by Application (2015-2020)
Table 124. Global Circulating Tumor Cell (CTC) Diagnostics Revenue Forecast by Application (2021-2025)
Table 125. Global Circulating Tumor Cell (CTC) Diagnostics Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Circulating Tumor Cell (CTC) Diagnostics Picture
Figure 2. Global Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share by Type in 2019
Figure 3. CTC Enrichment Picture
Figure 4. CTC Detection Picture
Figure 5. Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share by Application in 2019
Figure 6. Hospitals and clinics Picture
Figure 7. Pharmaceuticals and biotechnology companies Picture
Figure 8. Academic research institutes Picture
Figure 9. CROs Picture
Figure 10. Global Circulating Tumor Cell (CTC) Diagnostics Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America Circulating Tumor Cell (CTC) Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe Circulating Tumor Cell (CTC) Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America Circulating Tumor Cell (CTC) Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa Circulating Tumor Cell (CTC) Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Circulating Tumor Cell (CTC) Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Circulating Tumor Cell (CTC) Diagnostics Revenue Share by Players in 2019
Figure 18. Global Top 5 Players Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share in 2019
Figure 19. Global Top 10 Players Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global Circulating Tumor Cell (CTC) Diagnostics Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share by Regions (2015-2020)
Figure 23. Global Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share by Regions in 2018
Figure 24. North America Circulating Tumor Cell (CTC) Diagnostics Revenue and Growth Rate (2015-2020)
Figure 25. Europe Circulating Tumor Cell (CTC) Diagnostics Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics Revenue and Growth Rate (2015-2020)
Figure 27. South America Circulating Tumor Cell (CTC) Diagnostics Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa Circulating Tumor Cell (CTC) Diagnostics Revenue and Growth Rate (2015-2020)
Figure 29. North America Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 30. North America Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share by Countries in 2019
Figure 31. USA Circulating Tumor Cell (CTC) Diagnostics Revenue and Growth Rate (2015-2020)
Figure 32. Canada Circulating Tumor Cell (CTC) Diagnostics Revenue and Growth Rate (2015-2020)
Figure 33. Mexico Circulating Tumor Cell (CTC) Diagnostics Revenue and Growth Rate (2015-2020)
Figure 34. Europe Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 35. Europe Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share by Countries in 2019
Figure 36. Germany Circulating Tumor Cell (CTC) Diagnostics Revenue and Growth Rate (2015-2020)
Figure 37. UK Circulating Tumor Cell (CTC) Diagnostics Revenue and Growth Rate (2015-2020)
Figure 38. France Circulating Tumor Cell (CTC) Diagnostics Revenue and Growth Rate (2015-2020)
Figure 39. Russia Circulating Tumor Cell (CTC) Diagnostics Revenue and Growth Rate (2015-2020)
Figure 40. Italy Circulating Tumor Cell (CTC) Diagnostics Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share by Countries in 2019
Figure 43. China Circulating Tumor Cell (CTC) Diagnostics Revenue and Growth Rate (2015-2020)
Figure 44. Japan Circulating Tumor Cell (CTC) Diagnostics Revenue and Growth Rate (2015-2020)
Figure 45. Korea Circulating Tumor Cell (CTC) Diagnostics Revenue and Growth Rate (2015-2020)
Figure 46. India Circulating Tumor Cell (CTC) Diagnostics Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia Circulating Tumor Cell (CTC) Diagnostics Revenue and Growth Rate (2015-2020)
Figure 48. South America Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 49. South America Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share by Countries in 2019
Figure 50. Brazil Circulating Tumor Cell (CTC) Diagnostics Revenue and Growth Rate (2015-2020)
Figure 51. Argentina Circulating Tumor Cell (CTC) Diagnostics Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia Circulating Tumor Cell (CTC) Diagnostics Revenue and Growth Rate (2015-2020)
Figure 55. UAE Circulating Tumor Cell (CTC) Diagnostics Revenue and Growth Rate (2015-2020)
Figure 56. Egypt Circulating Tumor Cell (CTC) Diagnostics Revenue and Growth Rate (2015-2020)
Figure 57. South Africa Circulating Tumor Cell (CTC) Diagnostics Revenue and Growth Rate (2015-2020)
Figure 58. Global Circulating Tumor Cell (CTC) Diagnostics Revenue Share by Type (2015-2020)
Figure 59. Global Circulating Tumor Cell (CTC) Diagnostics Revenue Share by Type in 2019
Figure 60. Global Circulating Tumor Cell (CTC) Diagnostics Market Share Forecast by Type (2021-2025)
Figure 61. Global CTC Enrichment Revenue Growth Rate (2015-2020)
Figure 62. Global CTC Detection Revenue Growth Rate (2015-2020)
Figure 63. Global Circulating Tumor Cell (CTC) Diagnostics Revenue Share by Application (2015-2020)
Figure 64. Global Circulating Tumor Cell (CTC) Diagnostics Revenue Share by Application in 2019
Figure 65. Global Circulating Tumor Cell (CTC) Diagnostics Market Share Forecast by Application (2021-2025)
Figure 66. Global Hospitals and clinics Revenue Growth Rate (2015-2020)
Figure 67. Global Pharmaceuticals and biotechnology companies Revenue Growth Rate (2015-2020)
Figure 68. Global Academic research institutes Revenue Growth Rate (2015-2020)
Figure 69. Global CROs Revenue Growth Rate (2015-2020)
Figure 70. Global Circulating Tumor Cell (CTC) Diagnostics Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global Circulating Tumor Cell (CTC) Diagnostics Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America Circulating Tumor Cell (CTC) Diagnostics Revenue Market Forecast (2021-2025)
Figure 74. Europe Circulating Tumor Cell (CTC) Diagnostics Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics Revenue Market Forecast (2021-2025)
Figure 76. South America Circulating Tumor Cell (CTC) Diagnostics Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa Circulating Tumor Cell (CTC) Diagnostics Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel

---